[ACS] Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity In Vivo

 关闭 求助已关闭
假期 发表于 2026-8-27 10:31:57 | 显示全部楼层 |阅读模式
悬赏20积分


DOI号:10.1021/acs.jmedchem.6c00029

文献链接:Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity In Vivo | Journal of Medicinal Chemistry | ACS Publications

文献作者:Christopher P. Tinworth * ; Justyna Wojno-Picon; Michael Adam; Stephan Gade; Ashley P. Hancock; David J. Hirst; Jonathan P. Hutchinson; Semra Kitchen; Despoina Koumantou; Jonathan Lea; Stephanie Lehmann; John Liddle; Richard Lonsdale; Margarete Neu; Leng Nickels; Alex Phillipou; James E. Rowedder; Paul Rowland; Jessica L. Schneck; Paul Scott-Stevens; Hester Sheehan; Michael Steidel; Chloe L. Tayler; Ioannis Temponeras; Kevin Thang; David F. Tough; Giovanni Vitulli; Ian D. Wall; Robert J. Young; Nico Zinn; Simon Peace; Efstratios Stratikos *

备注信息:https://pubs.acs.org/jmcmar/arti ... rectedFrom=fulltext

已采纳

附件内容

查看完整内容

全部回复1 显示全部楼层
Shuochen 发表于 2026-8-27 10:31:58 | 显示全部楼层

当前求助已完成,请重新发起求助。

已完结状态的附件将会在24小时内删除。
注册会员
  • 发布

  • 回复

  • 积分

    40

返回列表